A study by Abdul Rahim et al. (2017) showed that ATG9A is essential for general GBM cell survival as a novel regulator of autophagy induction, and the inhibition of autophagy could be an effective therapy in GBM. The gene discussed is ATG9A; the disease is glioblastoma.